NanGenex Announce Global Launch of NanoActive
News Sep 09, 2009
NanGenex Inc. (formerly known as ComErgen) announced the global launch of its NanoActive. “The NanoActive™ technology provides nanoformulation solutions for original as well as generic applications in a wide variety of industries including pharmaceuticals, agrochemicals, cosmetics, foods, nutraceu home care.
“The proprietary NanoActive™ technology available top-down milling and high pressure homogenization based technologies. It is a bottom flow nano precipitation method for the synthesis of nanoparticles. The properties of the produced nanoparticles can be modified during the process by the precise control and optimization of various reaction parameters by as much as 90%”
The NanGenex partners acquire a license to the commercialize the NanoActive™ product or product families developed through the collaboration. In 2009, NanGenex expanded its patented including antihypertensives, cholesterol reducers, anti The NanoPharmaActive™ formulations have undergon the parent active molecules.
NanGenex explains that it is in advanced discussions with leading pharmaceutical a partnerships and strategic alliances for the development of novel nano. The drug nanoformulations can increase drug potency and reduce side effects. This brings clinically meaningful benefits to patients.
Exposure to Low Levels of BPA during Pregnancy Can Lead to Altered Brain DevelopmentNews
New research in mice provides an explanation for how exposure to the widely used chemical bisphenol A (BPA) during pregnancy, even at levels lower than the regulated “safe” human exposure level, can lead to altered brain development and behavior later in life.READ MORE
Moving Toward a Future Free of Drug-Induced Hearing LossNews
A new special publication orchestrated by five of the nation's leading hearing experts compiles the latest research into hearing loss caused by drugs and solvents - how it occurs, how to treat it, and how to prevent it.READ MORE
3-D Tissue Model of Developing Heart Could Aid Drug Safety Testing for Pregnant WomenNews
Parents and doctors often have to consider the mother's health as well as the potential risk regarding how medication could affect their baby. Researchers have developed a process to make a 3D tissue model that could mimic early stage human heart development, which could aid drug safety testing and help determine a drug's effects on fetal development.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018